Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan-Reference-Cited by-同舟云学术

Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan

Published:2016-07-06 Issue:2 Volume:89 Page:284-290
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Akuta Norio¹,Sezaki Hitomi¹,Suzuki Fumitaka¹,Fujiyama Shunichiro¹,Kawamura Yusuke¹,Hosaka Tetsuya¹,Kobayashi Masahiro¹,Kobayashi Mariko²,Saitoh Satoshi¹,Suzuki Yoshiyuki¹,Arase Yasuji¹,Ikeda Kenji¹,Kumada Hiromitsu¹

Affiliation:

1. Department of Hepatology; Toranomon Hospital, and Okinaka Memorial Institute for Medical Research; Tokyo Japan

2. Liver Research Laboratory; Toranomon Hospital; Tokyo Japan

Funder

Ministry of Health, Labor and Welfare, Japan

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference18 articles.

1. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection;Afdhal;N Engl J Med,2014a

2. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection;Afdhal;N Engl J Med,2014b

3. Emergence of telaprevir-resistant variants detected by ultra-deep sequencing after triple therapy in patients infected with HCV genotype 1;Akuta;J Med Virol,2013

4. Projecting future complications of chronic hepatitis C in the United States;Davis;Liver Transpl,2003

5. In vitro assessment of re-treatment options for patients with hepatitis C virus genotype 1b infection resistant to daclatasvir plus asunaprevir;Friborg;Infect Dis Ther,2014

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment progress and expansion in Japan: From interferon to direct-acting antiviral;Global Health & Medicine;2021-10-31

2. Resistance-associated substitutions and response to treatment in a chronic hepatitis C virus infected-patient: an unusual virological response case report;BMC Infectious Diseases;2021-04-26

3. Real‐world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan;Journal of Viral Hepatitis;2020-09-16

4. The outlook for precision medicine for the treatment of chronic hepatitis C infection: challenges and opportunities;Expert Review of Precision Medicine and Drug Development;2020-06-09

5. Japan Society of Hepatology guidelines for the management of hepatitis C virus infection: 2019 update;Hepatology Research;2020-05-29